CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 34 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $792,000 | +486.7% | 150,357 | +121.9% | 0.02% | +566.7% |
| Q3 2016 | $135,000 | +82.4% | 67,748 | +94.8% | 0.00% | +50.0% |
| Q1 2016 | $74,000 | -60.6% | 34,771 | -4.9% | 0.00% | -33.3% |
| Q2 2015 | $188,000 | +15.3% | 36,555 | +57.1% | 0.00% | 0.0% |
| Q4 2014 | $163,000 | +64.6% | 23,263 | +42.3% | 0.00% | +50.0% |
| Q3 2014 | $99,000 | +15.1% | 16,353 | +54.8% | 0.00% | +100.0% |
| Q1 2014 | $86,000 | – | 10,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|